Advanced Search

Technical Analysis for GOSS - Gossamer Bio, Inc.

Grade Last Price % Change Price Change
grade D 13.56 0.82% 0.11
GOSS closed up 0.82 percent on Friday, August 7, 2020, on 83 percent of normal volume.
3 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical GOSS trend table...
Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
MACD Bullish Centerline Cross Bullish 0.00%
Outside Day Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
Crossed Above 20 DMA Bullish 0.82%
Up 3 Days in a Row Strength 0.82%
Up 4 Days in a Row Strength 0.82%
50 DMA Support Bullish 2.42%
Older EOD signals for GOSS ...
View Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators Basic chart:

Profile

Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.
Biopharmaceutical Life Sciences Disease Inflammation Millennium Pharmaceuticals Takeda Pharmaceutical Company Trubion

Is GOSS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Aug 5 Gossamer Bio Announces Data Presentations at the American Thoracic Society 2020 Virtual Conference
Jul 22 Could The Gossamer Bio, Inc. (NASDAQ:GOSS) Ownership Structure Tell Us Something Useful?
Jul 22 Gossamer Bio's Shares March Higher, Can It Continue?
Jul 3 Is Gossamer Bio, Inc. (GOSS) A Good Stock To Buy?
Jun 12 Gossamer Bio (GOSS) Investor Presentation - Slideshow
Jun 8 Aerpio Hosting Key Opinion Leader Call on a Novel Mechanism for the Treatment of Glaucoma
Jun 2 GOSS FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Gossamer Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: June 2, 2020
Jun 2 LAWSUITS FILED AGAINST GOSS, LBRT and FITB - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
Jun 2 FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Gossamer Bio, Inc. and Encourages Investors with Losses to Contact the Firm
Jun 2 The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, SERV and BBBY
See more GOSS news...

Indicators

Indicator Value
52 Week High 27.1497
52 Week Low 7.52
Average Volume 617,388
200-Day Moving Average 14.96
50-Day Moving Average 12.91
20-Day Moving Average 13.38
10-Day Moving Average 12.98
Average True Range 0.71
ADX 15.74
+DI 21.39
-DI 16.70
Chandelier Exit (Long, 3 ATRs ) 13.30
Chandelier Exit (Short, 3 ATRs ) 13.96
Upper Bollinger Band 14.76
Lower Bollinger Band 12.00
Percent B (%b) 0.57
BandWidth 20.58
MACD Line 0.01
MACD Signal Line 0.03
MACD Histogram -0.0202
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.76
Resistance 3 (R3) 14.71 14.25 14.56
Resistance 2 (R2) 14.25 13.95 14.28 14.49
Resistance 1 (R1) 13.91 13.76 14.08 13.96 14.43
Pivot Point 13.45 13.45 13.54 13.48 13.45
Support 1 (S1) 13.11 13.15 13.28 13.16 12.69
Support 2 (S2) 12.65 12.96 12.68 12.63
Support 3 (S3) 12.31 12.65 12.56
Support 4 (S4) 12.36